Trump Says He Cannot Forgive Enemies in CBS Interview
November 9, 2026
Lismore Named in National Whooping Cough Warning
Lismore and the Northern Rivers feature in a national whooping cough warning. Local case totals and corridor boundaries remain unclear.
November 9, 2026
Caris Raises 2026 Outlook as Cancer Test Expansion Looms
Caris targets $1.04B-$1.05B in 2026 revenue and about 65,000 Q4 clinical cases, alongside MRD launches and MCED rollout risks.
November 5, 2026
FDA Greenlights Divalproex Sodium as a New Therapy Option
The FDA has approved Divalproex Sodium, a new treatment for epilepsy and bipolar disorder, promising improved patient outcomes and market growth.
July 11, 2026
FDA Greenlights AMONDYS 45 for Duchenne Muscular Dystrophy
The FDA has approved AMONDYS 45, a new treatment for Duchenne Muscular Dystrophy, priced at $240,000 annually, changing patient care options in the U....
July 11, 2026
FDA Greenlights OLANZAPINE: A New Era in Mental Health Treatment
The FDA has approved OLANZAPINE, a new treatment for mental health disorders, offering hope to millions as it enters the market in early 2015.
July 11, 2026
FDA Greenlights DAPSONE: A New Hope for Patients
The FDA has approved DAPSONE, a new treatment option that holds promise for patients with leprosy and dermatitis herpetiformis, priced at $21 per tabl...
July 11, 2026
FDA Greenlights Acetaminophen and Codeine Phosphate for Pain Relief
The FDA has approved Acetaminophen and Codeine Phosphate, a new medication for moderate to severe pain, priced at about $1.25 per tablet.
July 11, 2026
FDA Grants Approval for TRAMADOL HYDROCHLORIDE as Pain Relief
The FDA has approved TRAMADOL HYDROCHLORIDE, a new opioid analgesic for moderate pain management, as part of ongoing efforts to address the opioid cri...
July 10, 2026
FDA Greenlights BRIUMVI as a New MS Treatment Option
The FDA has approved BRIUMVI, a new treatment for multiple sclerosis, offering hope to over 1 million Americans living with the condition.
July 10, 2026